Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a novel antisense transcript at the HPCAL4 locus (Ensembl ID ENSG00000293757). Antisense transcripts are RNA molecules transcribed from the opposite DNA strand relative to a protein-coding gene, often regulating the expression of the sense transcript through mechanisms such as RNA interference, transcriptional interference, or epigenetic modification. However, for this specific transcript, there is no current experimental evidence describing a biological function, disease involvement, molecular classification, or druggability. It is best characterized as a potentially regulatory but unvalidated genomic transcript, not a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to HPCAL4 (ENSG00000293757).